title: Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy.
authors.affiliation: Centre de Recherche sur l'Inflammation (CRI), UMR 1149 Inserm, Université Paris Diderot, Service d'Hépatologie, AP-HP Hôpital Beaujon, Clichy, France. Electronic address: tarik.asselah@bjn.aphp.fr.
authors.forename: Tarik
authors.initials: T
authors.lastname: Asselah
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*
chemical_list: D000998:Antiviral Agents; D007093:Imidazoles; D017361:Viral Nonstructural Proteins; D014542:Uridine Monophosphate
keywords: Daclatasvir; Direct-acting antivirals; Faldaprevir; Simeprevir; Sofosbuvir